Brind.

Recordati's board approved interim financial statements, which were published from Milan on July 28, 2026.

3 reports, 2 independent Updated Jul 29
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Recordati's board approved interim financial statements, which were published from Milan on July 28, 2026.

Who's involved

What this event is mainly about
Recordati

Keep exploring

The entities involved

  • Recordati

    Italian pharmaceutical company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • finanznachrichten.de
  • investegate.co.ukRECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7% | Company Announcement | Investegate
1 more outlet ran the same wire story